Drug nephrotoxicity: An overview

Renal Failure

Volumn 19, Issue 2, 1997, Pages 221-224

  Bennett, William M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CREATININE; CYCLOSPORIN; GENTAMICIN; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA;

ACUTE KIDNEY FAILURE; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; HUMAN; NEPHROTOXICITY; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL;

EID: 0030961547     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229709026280     Document Type: Conference Paper

References (28)

1. Humes HD: Amnioglycoside nephrotoxicity. Kidney Int 33:900-911, 1988.
2. Bennett WM: Mechanisms of aminoglycoside nephrotoxicity. Clin Exp Pharmacol Physiol 16:1-6, 1989.
3. Gilbert D, Wood C, Kohlhepp S, Kohnen P, Houghton DC, Finkbeiner H, Lindsley J, Bennet WM: Polyaspartic acid prevents experimental aminoglycoside nephrotoxicity. J Infect Dis 159:945-953, 1989.
4. Nicolau DP, Freeman CD, Belliveau PP, Nightingale CH, Ross JW, Quintiliani R: Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother 39: 650-655, 1995.
5. Bennet WM, Plamp CE, Gilbert DN, Parker RA, Porter GA: The influence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure. J Infect Dis 140: 576-580, 1979.
6. Moestrup SK, Cui S, Vorum H, Bregengard C, Bjorn SE, Norris K, Gliemann J, Christensen EI: Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs. J Clin Invest 96:1404-1413, 1995.
7. Blackshear JL, Davidman M, Stillman MT: Identification of risk for renal insufficiency from nonsteroidal anti-inflammatory drugs. Arch Intern Med 143:1130-1134, 1983.
8. Mujais RA, Battle D: Functional correlations of tubulo-interstitial damage. Semin Nephrol 8:94-99, 1988.
9. Clive DM, Stoff JS: Renal syndromes associated with nonsteroidal anti-inflammatory drugs. N Engl J Med 310:563-572, 1984.
10. English J, Evan A, Houghton DC, Bennet WM: Cyclosporine-induced acute renal dysfunction in the rat: evidence of arteriolar vasoconstriction with preservation of tubular function. Transplantation 44:135-141, 1987.
11. Curtis JJ, Luke RG, Dubovsky E, Diethelm AG, Whelchel JD, Jones P: Cyclosporin in therapeutic doses increases renal allograft vascular resistance. Lancet 2:477-479, 1986.
12. Perico N, Ruggenenti P, Gaspari F, Mosconi L, Benigni A, Amuchastegui CS, Gasparini F, Remuzzi G: Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation. Transplantation 54:56-60, 1992.
13. Dumont FJ, Staruch MJ, Koprak SL, Siekierka JJ, Lin CS, Harrison R, Sewell T, Kindt VM, Beattie TR, Wyvratt M, Sigal NH: The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin. J Exp Med 176:751-760, 1992.
14. Benigni A, Morigi M, Perico N, Zoja C, Amuchastegui CS, Piccinelli A, Donadelli R, Remuzzi G: The acute effect of FK506 and cyclosporine on endothelial cell function and renal vascular resistance. Transplantation 54:775-780, 1992.
15. Kon V, Hunley TE, Fogo A: Combined antagonism of endothelin A/B receptors links endothelin to vasoconstriction whereas angiotensin II effects fibrosis: studies in chronic cyclosporine nephrotoxicity in rats. Transplantation 60:89-95, 1995.
16. Serino F, Grevel J, Napoli KL, Kahan BD, Strobel UW: Generation of oxygen free radicals during the metabolism of cyclosporine A: a cause-effect relationship with metabolism inhibition. Mol Cell Bioichem 122:101-112, 1993.
17. Brady HR, Singer GG: Acute renal failure. Lancet 346:1533-1540, 1995.
18. Conger JD: Interventions in clinical acute renal failure: what are the data? Am J Kidney Dis 26:565-576, 1995.
19. Zager RA: Acute renal failure in the setting of bone marrow transplantation. Kidney Int 46:1443-1458, 1994.
20. Elseviers MM, De Schepper A, Corthouts R, Bosmans JL, Cosyn L, Lins RL, Lornoy W, Matthys E, Roose R, Van Caesbroeck D, Waller I, Horackova M, Schwarz A, Svrcek P, Bonucchi D, Franek E, Morlans M, De Broe ME: High diagnostic performance of CT scan for analgesic nephropathy in patients with incipient to severe renal failure. Kidney Int 48:1316-1323, 1995.
21. Elseviers MM, De Broe ME: A long-term prospective controlled study of analgesic abuse in Belgium. Kidney Int 48:1912-1919, 1995.
22. Henrich WL, Agodoa LE, Barrett B, Bennett WM, Blantz RC, Buckalew VMJ, D' Agati VD, De Broe ME, Duggin GG, Ekoyan G, Elseviers MM, Gomez RA, Matzke GR, Porter GA, Sabatini S, Stoff JS, Striker GE, Winchester JF: Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the National Kidney Foundation. Am J Kidney Dis 27:162-165, 1996.
23. Segasothy M, Samad SA, Zulfigar A, Bennett WM: Chronic renal disease and papillary necrosis associate with the long term use of nonsteroidal anti-inflammatory drugs as a sole or predominent analgesic. Am J Kidney Dis 24:17-24, 1994.
24. Feutren G, Mihatsch MJ: Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases: international kidney biopsy registry of cyclosporine in autoimmune diseases. N Engl J Med 326:1654-1660, 1992.
25. Myers BD, Newton L, Boshkos C, Macoviak JA, Frist WH, Derby GC, Perlroth MG, Sibley RK: Chronic injury of human renal microvessels with low-dose cyclosporine therapy. Transplantation 46:694-703, 1988.
26. Elzinga LW, Rosen S, Bennett WM: Dissociation of glomerular filtration rate from tubulointerstitial fibrosis in experimental chronic cyclosporine nephropathy: role of sodium intake. J Am Soc Nephrol 4:214-221, 1993.
27. Shehata M, Cope GH, Johnson TS, Raftery AT, el Nahas Am: Cyclosporine enhances the expression of TGF-β in die juxtaglomerular cells of die rat kidney. Kidney Int 48:1487-1496, 1995.
28. Bennett WM, DeMattos A, Myer MM, Andoh T, Barry JM: Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy. Kidney Int in press.